我们最终是如何采用一种将至少两种抗生素与质子泵抑制剂联合使用的四联疗法来根除（幽门螺杆菌）的呢？
How Did We End Up Using a Quadruple Guided Therapy Combining At Least Two Antibiotics with a PPI to Eradicate ?
作者信息
Pichon Maxime, Cremniter Julie, Burucoa Christophe
机构信息
CHU Poitiers, Infectious Agents Department, Bacteriology Laboratory, 86021 Poitiers, France.
INSERM U1070 Pharmacology of Antimicrobial Agents and Antibiotic Resistance, University of Poitiers, 86073 Poitiers, France.
出版信息
J Clin Med. 2022 Sep 3;11(17):5216. doi: 10.3390/jcm11175216.
Abstract
Since the discovery of , and even if the species is frequently susceptible to many antibiotics , only six of them (amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, and rifabutin) and bismuth salts could be considered as effective to eliminate and have been used in recommended eradication treatments [...].
摘要
自从发现……以来，即使该物种通常对多种抗生素敏感，但其中只有六种（阿莫西林、克拉霉素、甲硝唑、四环素、左氧氟沙星和利福布汀）以及铋盐可被认为对根除……有效，并已用于推荐的根除治疗中[……]
相似文献
1
How Did We End Up Using a Quadruple Guided Therapy Combining At Least Two Antibiotics with a PPI to Eradicate ?我们最终是如何采用一种将至少两种抗生素与质子泵抑制剂联合使用的四联疗法来根除（幽门螺杆菌）的呢？
J Clin Med. 2022 Sep 3;11(17):5216. doi: 10.3390/jcm11175216.
2
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.《多伦多成人幽门螺杆菌感染治疗共识》。
Gastroenterology. 2016 Jul;151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006. Epub 2016 Apr 19.
3
'Rescue' therapies for the management of Helicobacter pylori infection.用于幽门螺杆菌感染治疗的“挽救”疗法。
Dig Dis. 2006;24(1-2):113-30. doi: 10.1159/000090315.
4
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.在非铋剂四联“序贯”或“联合”疗法根除幽门螺杆菌感染失败后，采用左氧氟沙星进行二线挽救三联疗法。
Scand J Gastroenterol. 2013 Jun;48(6):652-6. doi: 10.3109/00365521.2013.786132. Epub 2013 Apr 5.
5
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.一项随机对照试验表明，在抗生素耐药率中等的人群中，14 天的混合疗法和铋四联疗法都能治愈大多数幽门螺杆菌感染患者。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00140-17. Print 2017 Nov.
6
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.幽门螺杆菌在存在青霉素过敏的情况下的一线和挽救治疗。
Dig Dis Sci. 2015 Feb;60(2):458-64. doi: 10.1007/s10620-014-3365-2. Epub 2014 Sep 19.
7
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
8
Helicobacter pylori eradication therapy.幽门螺杆菌根除治疗。
Future Microbiol. 2010 Apr;5(4):639-48. doi: 10.2217/fmb.10.25.
9
A new look at anti-Helicobacter pylori therapy.重新审视抗幽门螺杆菌治疗。
World J Gastroenterol. 2011 Sep 21;17(35):3971-5. doi: 10.3748/wjg.v17.i35.3971.
10
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for infection.铋剂四联疗法中阿莫西林或四环素作为一线治疗 感染。
Gut Microbes. 2020 Sep 2;11(5):1314-1323. doi: 10.1080/19490976.2020.1754118. Epub 2020 May 2.
引用本文的文献
1
Effectiveness of Rifabutin-Based Regimens in Treating Helicobacter pylori Infections.基于利福布汀的治疗方案对幽门螺杆菌感染的疗效
Cureus. 2023 Dec 14;15(12):e50541. doi: 10.7759/cureus.50541. eCollection 2023 Dec.
本文引用的文献
1
Guided Treatment of Infections with Non-Invasive PCR Tests-The Glory Days of Primary Care?非侵入性PCR检测指导下的感染治疗——基层医疗的辉煌时代？
J Clin Med. 2022 Jul 25;11(15):4320. doi: 10.3390/jcm11154320.
2
Mutations Associated to Antibiotic-Resistant : It Is Time to Validate Sequencing Observations.与抗生素耐药性相关的突变：是时候验证测序观察结果了。
J Clin Med. 2022 Jul 24;11(15):4293. doi: 10.3390/jcm11154293.
3
New Strategy for the Detection and Treatment of Infections in Primary Care Guided by a Non-Invasive PCR in Stool: Protocol of the French HepyPrim Study.基于粪便非侵入性PCR检测的基层医疗中感染性疾病诊治新策略：法国HepyPrim研究方案
J Clin Med. 2022 Feb 22;11(5):1151. doi: 10.3390/jcm11051151.
4
Where to Biopsy to Detect and How Many Biopsies Are Needed to Detect Antibiotic Resistance in a Human Stomach.在人体胃部何处进行活检以检测以及需要进行多少次活检才能检测出抗生素耐药性
J Clin Med. 2020 Aug 31;9(9):2812. doi: 10.3390/jcm9092812.
5
Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay.使用Amplidiag幽门螺杆菌+克拉霉素实时PCR检测法对粪便中幽门螺杆菌及克拉霉素耐药性进行非侵入性检测的诊断准确性
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01787-19.
6
Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota.治疗幽门螺杆菌感染及其对肠道微生物群的长期影响。
J Gastroenterol Hepatol. 2020 Jul;35(7):1107-1116. doi: 10.1111/jgh.14992. Epub 2020 Feb 14.
7
Impact of the Gastro-Intestinal Bacterial Microbiome on -Associated Diseases.胃肠道细菌微生物群对相关疾病的影响。
Healthcare (Basel). 2019 Feb 22;7(1):34. doi: 10.3390/healthcare7010034.
8
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
9
Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study.在健康成年男性受试者中，与埃索美拉唑 20mg 或雷贝拉唑 10mg 相比，沃诺拉赞 20mg 的抑酸作用——一项随机、开放标签交叉研究。
Aliment Pharmacol Ther. 2015 Sep;42(6):719-30. doi: 10.1111/apt.13325. Epub 2015 Jul 21.
10
Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection.幽门螺杆菌感染根除治疗的药理学方面。
Gastroenterol Clin North Am. 2010 Sep;39(3):465-80. doi: 10.1016/j.gtc.2010.08.007.
Zotero 插件